US markets continue recovery with Eli Lilly and Johnson & Johnson rising
- 1The S&P 500 continued its recovery on Monday, recording a gain of over 2%.
- 2Eli Lilly rose more than 4% after announcing positive late-stage clinical results for its weight-loss drug Foundayo.
- 3Johnson & Johnson shares rose, climbing slightly above 2%.
So what's the key point?
The US stock market rebounded with significant gains. Eli Lilly rose more than 4% following positive drug trial results, and Johnson & Johnson also saw an increase.
Source CNBC · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.